Sterol Regulatory Element-Binding Protein 1 (Sre1) in Schizosaccharomyces pombe is a transcription factor crucial for maintaining lipid homeostasis and regulating the response to low oxygen conditions . Sre1 belongs to the SREBP family, which are master regulators of cellular lipid metabolism .
Regulation of Lipid Homeostasis: Sre1 controls the transcription of genes involved in sterol biosynthesis, ensuring proper levels of ergosterol, an essential sterol in yeast .
Oxygen Sensing: Sre1 indirectly measures oxygen availability through oxygen-dependent sterol synthesis. Under low oxygen conditions, Sre1 activates genes required for adaptation to hypoxia .
Anaerobic Gene Expression: Sre1 is a principal regulator of anaerobic gene expression, controlling a significant portion of genes induced under anaerobic conditions .
Sre1-Scp1 Complex: Sre1 functions in complex with Scp1, a protein homologous to mammalian Scap (SREBP cleavage-activating protein) . Scp1 binds and stabilizes Sre1 in the endoplasmic reticulum (ER) membrane .
ER to Golgi Transport: Under low sterol or low oxygen conditions, Scp1 escorts Sre1 from the ER to the Golgi apparatus .
Proteolytic Cleavage: In the Golgi, Sre1 is proteolytically cleaved to release the active N-terminal transcription factor fragment (Sre1N) . This process requires the Dsc E3 ubiquitin ligase complex and the proteasome .
Nuclear Translocation and Transcriptional Activation: After release, Sre1N enters the nucleus and promotes the transcription of sterol synthesis and oxygen-responsive genes . It also up-regulates its own expression through a positive feedback loop .
Ergosterol, a sterol synthesized in yeast, plays a crucial role in regulating Sre1 activity . Sre1-Scp1 senses ergosterol levels in the endoplasmic reticulum . A quantitative relationship exists between ergosterol concentration and Sre1 activation, where low ergosterol levels trigger Sre1 activation to enhance sterol synthesis .
Sre1 is coordinately regulated with another transcription factor, Mga2, which regulates triacylglycerol and glycerophospholipid synthesis . Sre1 cleavage is affected by Mga2 activity, linking sterol synthesis to fatty acid synthesis .
A homolog of Sre1 is found in the fungus Botrytis cinerea, where it regulates development, pathogenicity, and adaptation to host tissue environments . Deletion of SRE1 in B. cinerea results in reduced conidiation, increased sclerotium production, and decreased ergosterol biosynthesis .
In Xanthophyllomyces dendrorhous, Sre1 regulates genes in the mevalonate pathway and ergosterol biosynthesis . Mutation of SRE1 reduces sterol and carotenoid production, while overexpression of the Sre1 N-terminal domain increases carotenoid production .
Sre1 is crucial for adaptation to hypoxia . Under low oxygen conditions, Sre1 is activated to promote the transcription of genes involved in sterol synthesis and other oxygen-responsive genes . In B. cinerea, deletion of SRE1 leads to abnormal germination and reduced growth under low-oxygen conditions .
Sre1 negatively mediates sclerotium production in Botrytis cinerea . Deletion of SRE1 results in a significant increase in the number of sclerotia produced .
Sre1 is essential for conidiation in Botrytis cinerea . Deletion of SRE1 drastically reduces the production of conidia .
| Aspect | Δsre1 Phenotype in B. cinerea | Wild-Type Phenotype in B. cinerea |
|---|---|---|
| Conidiation | Reduced to 3% | Normal |
| Sclerotium Production | Increased six-fold | Normal |
| Ergosterol Content | Reduced by half | Normal |
| Hypoxia Adaptation | Abnormal germination/growth | Normal germination/growth |
| Imidazole Resistance | Increased | Normal |
Sterol regulatory element-binding protein 1 (Sre1) precursor is a membrane-bound protein residing within the endoplasmic reticulum. Under conditions of low oxygen or sterol levels, it undergoes processing, releasing the transcription factor form which translocates to the nucleus. This active form then initiates transcription of genes crucial for anaerobic growth adaptation, encompassing pathways involved in sterol, heme, sphingolipid, and ubiquinone biosynthesis. Sre1 may function as an oxygen sensor through its involvement in oxygen-requiring sterol synthesis steps.
KEGG: spo:SPBC19C2.09
STRING: 4896.SPBC19C2.09.1
Sre1 in S. pombe is synthesized as an inactive transmembrane protein anchored to the endoplasmic reticulum (ER). It contains an N-terminal domain with a basic helix-loop-helix (bHLH) leucine zipper DNA binding motif facing the cytoplasm. The protein has two transmembrane segments and a C-terminal regulatory domain that interacts with SCAP (known as Scp1 in fungi). Compared to homologs in other fungi like X. dendrorhous, the S. pombe Sre1 has distinctive features such as the conserved tyrosine residue in the bHLH motif, an N-terminal domain rich in serine and proline residues, and the two characteristic transmembrane helices after the bHLH motif . When studying recombinant Sre1, it's important to note that some organisms like X. dendrorhous have Sre1 proteins with shorter C-terminal domains and lack the DUF2014 domain present in other SREBPs, which may indicate different activation mechanisms .
Sre1 activation in S. pombe follows a sterol-dependent regulatory pathway. Under normal conditions, the Sre1-Scp1 complex remains anchored to the ER membrane through interaction with sterols. When cellular sterol levels decrease, the Sre1-Scp1 complex is transported to the Golgi apparatus where Sre1 undergoes proteolytic cleavage, releasing the transcriptionally active N-terminal domain (Sre1N). This cleaved form then translocates to the nucleus to regulate target gene expression . The activation mechanism differs from some other fungi; for example, while S. pombe has an INSIG encoding gene homolog, its deletion doesn't affect Sre1 activation unlike in mammalian systems . Experimental approaches to study activation typically involve creating sterol-depleted conditions through genetic manipulations or pharmacological inhibitors of sterol biosynthesis.
In S. pombe, Sre1N primarily activates the transcription of genes involved in three main pathways: sterol biosynthesis, lipid metabolism, and hypoxic response . Specific targets include genes in the mevalonate pathway and genes involved in ergosterol biosynthesis. Experimental identification of these targets typically employs chromatin immunoprecipitation (ChIP) followed by PCR or sequencing, as well as RNA-seq analysis comparing wild-type and sre1- mutant strains. Research has shown that genes with Sterol Regulatory Elements (SREs) in their promoter regions are direct targets of Sre1 binding, with the mevalonate pathway genes HMGS and HMGR being well-characterized examples in various organisms . To experimentally validate Sre1 targets, researchers often use both in vitro approaches like Electrophoretic Mobility Shift Assays (EMSA) and in vivo methods like ChIP-PCR to confirm direct binding to promoter regions.
For recombinant expression of S. pombe Sre1, researchers typically clone the N-terminal domain (containing the bHLH motif) into bacterial expression vectors. Expression in E. coli BL21(DE3) strain with a 6xHis tag allows for efficient purification using nickel affinity chromatography. When expressing full-length Sre1, which contains transmembrane domains, eukaryotic expression systems such as insect cells or yeast may provide better results for proper protein folding. Purification protocols often include:
Cell lysis using sonication in buffer containing protease inhibitors
Clarification by centrifugation (20,000 g, 30 min)
Binding to Ni-NTA resin
Washing with increasing imidazole concentrations
Elution with high imidazole buffer (250-300 mM)
Dialysis to remove imidazole
For functional studies of the DNA-binding capability, EMSA assays can be performed using purified Sre1N and DNA fragments containing SRE sequences . This approach has been successfully used to demonstrate that the bHLH domain of Sre1 binds specifically to SRE sequences in vitro, confirming its function as a transcription factor.
Several genetic approaches have proven effective for investigating Sre1 function in S. pombe:
Gene deletion (sre1-): Complete knockout of Sre1 allows researchers to identify phenotypes and compare gene expression profiles between wild-type and mutant strains. This approach revealed that Sre1 is essential for growth under anaerobic conditions and in the presence of cobalt chloride (a hypoxia-mimicking agent) .
Domain-specific mutants: Expressing only the N-terminal domain (Sre1N) creates a constitutively active transcription factor, allowing the study of target gene activation independent of sterol levels.
Promoter replacement: Replacing the native Sre1 promoter with regulatable promoters enables controlled expression.
Epitope tagging: Adding tags like FLAG or HA facilitates ChIP experiments to identify DNA-binding sites.
Point mutations: Creating specific mutations in functional domains helps elucidate structure-function relationships.
Complementation assays: Testing if S. pombe Sre1 can restore function in sre1- mutants from other species provides insights into evolutionary conservation .
A particularly informative approach involves RNA-seq analysis comparing gene expression profiles between wild-type, sre1-, and Sre1N-expressing strains to identify direct and indirect Sre1 targets, as demonstrated in research with X. dendrorhous .
The most informative phenotypic assays for characterizing Sre1 mutants in S. pombe include:
Growth under hypoxic conditions: S. pombe sre1- mutants cannot grow under anaerobic conditions, making this a definitive assay for Sre1 functionality .
Cobalt chloride sensitivity: Growth inhibition in the presence of CoCl₂ (a hypoxia-mimicking agent) is characteristic of sre1- mutants .
Azole resistance: Sre1 is essential for growth in the presence of inhibitors of ergosterol synthesis such as azoles, making azole sensitivity a useful phenotypic marker .
Sterol profiling: Quantitative analysis of sterols using gas or liquid chromatography coupled with mass spectrometry reveals alterations in sterol biosynthesis in sre1 mutants.
Gene expression analysis: RT-qPCR of known Sre1 targets like HMGS and HMGR provides a molecular phenotype assessment .
Cell wall integrity assays: Since Sre1 indirectly affects cell wall composition, assays using cell wall-disrupting agents like Calcofluor White can be informative.
These assays collectively provide a comprehensive characterization of Sre1 function in cellular physiology and sterol homeostasis.
Sre1 in S. pombe interacts with multiple signaling pathways, creating a complex regulatory network. Research has revealed several key interactions:
Rho GTPase signaling: While not directly shown for Sre1, S. pombe protein kinase C homologues (pck1p and pck2p) interact with rho1p and rho2p GTPases in their GTP-bound forms. These interactions occur at the amino-terminal region containing HR1 motifs, stabilizing the kinases . Given that both pathways affect cell wall integrity, cross-talk is likely.
Ras/Ral signaling: Evidence suggests functional links between pck1+ and the ras1+ and ral1+ pathways . Since Sre1 regulates sterol metabolism which affects membrane properties where Ras proteins function, these pathways may influence each other.
Cell integrity pathways: The maintenance of cell integrity in S. pombe involves multiple factors, with 20 factors required for donor selection in mating-type switching having been identified . These pathways may overlap with Sre1 functions, particularly under stress conditions.
To experimentally investigate these interactions, researchers typically use genetic approaches such as creating double mutants (e.g., sre1- combined with mutations in other signaling components) and performing epistasis analysis to determine the hierarchy of gene functions.
Sre1 plays a central role in the hypoxic response in S. pombe, similar to its homologs in other fungi like C. neoformans and A. fumigatus. The relationship between Sre1 activation and hypoxic response involves several key mechanisms:
Oxygen-dependent regulation: Oxygen is required for ergosterol biosynthesis, and under hypoxic conditions, sterol levels decrease, triggering Sre1 activation.
Hypoxia-specific phenotypes: S. pombe sre1- mutants are unable to grow under anaerobic conditions or in the presence of cobalt chloride, a chemical that mimics hypoxia . This phenotype can be rescued by complementation with the native gene, confirming Sre1's essential role in hypoxic adaptation.
Transcriptional regulation: Under hypoxic conditions, activated Sre1N upregulates genes involved in oxygen-dependent processes, particularly sterol biosynthesis, to maintain cellular functions despite limited oxygen availability.
Adaptation mechanisms: The Sre1 pathway allows cells to adapt to low oxygen by modifying membrane composition and metabolic pathways to optimize oxygen utilization.
Experimentally, the relationship between Sre1 and hypoxia can be studied using controlled oxygen conditions in bioreactors, chemical hypoxia mimics like cobalt chloride , and comparative transcriptomics of wild-type and sre1- strains under various oxygen tensions.
Post-translational modifications (PTMs) play critical roles in regulating Sre1 activity, though specific details for S. pombe Sre1 are still being elucidated. Based on the available research and knowledge from related systems:
Proteolytic processing: The primary regulatory mechanism involves proteolytic cleavage of Sre1 in the Golgi apparatus, releasing the active N-terminal domain (Sre1N) . This process is regulated by sterol levels and requires the SCAP homolog Scp1.
Protein stability regulation: The GTP-bound form of Rho1p dramatically stabilizes protein kinases in S. pombe , suggesting that similar mechanisms might affect Sre1 stability, particularly since both pathways are involved in cell wall integrity.
Phosphorylation: While not explicitly demonstrated for S. pombe Sre1 in the provided search results, studies in other systems suggest that phosphorylation of the N-terminal domain can affect DNA binding activity, nuclear localization, and protein stability.
Ubiquitination: The search results mention the H2B ubiquitin ligase HULC and the BRE1-like ubiquitin ligase Brl2 as being involved in processes related to Sre1 function , suggesting potential regulation through ubiquitination pathways.
To study these modifications experimentally, researchers typically use mass spectrometry-based proteomics, phospho-specific antibodies, and genetic approaches targeting specific modifying enzymes.
Optimizing ChIP protocols for genome-wide Sre1 binding site identification requires careful consideration of several factors:
Research has demonstrated that Sre1 binds directly to SRE sequences in target gene promoters, as validated by both in vitro EMSA assays and in vivo ChIP-PCR for genes like HMGS .
Resolving contradictory findings regarding Sre1 target genes requires a multi-faceted approach that addresses variability in experimental systems:
Standardized experimental conditions: Establish consistent growth conditions, particularly regarding oxygen levels and sterol content, which significantly affect Sre1 activation.
Integrative genomic approaches:
Combine ChIP-seq data with RNA-seq from wild-type and sre1- strains
Use time-course experiments to distinguish primary from secondary effects
Apply network analysis to identify direct versus indirect regulation
Validation through multiple techniques:
Confirm binding with both in vitro (EMSA) and in vivo (ChIP-PCR) methods
Verify transcriptional effects using reporter assays
Perform mutagenesis of putative binding sites to establish causality
Cross-species comparisons: Compare Sre1 targets across related fungi with careful normalization for evolutionary distance. For example, research has shown differential roles of Sre1 between S. pombe, where it primarily regulates sterol biosynthesis and hypoxic response, and X. dendrorhous, where it additionally regulates carotenoid biosynthesis .
Biological context consideration: Account for strain background differences, growth phase, and stress conditions that may alter the Sre1 regulon.
A particularly effective approach is to create a "consensus regulon" by identifying genes that respond to Sre1 across multiple experimental systems and validation methods, as demonstrated by comparative analysis between S. pombe and other fungi .
Comparative analysis of Sre1 between S. pombe and pathogenic fungi reveals important similarities and differences with significant implications for antifungal development:
Key functional differences and research implications:
Conservation of core mechanism: The basic activation mechanism involving sterol-dependent processing appears conserved, but with variations in the processing machinery. For instance, some fungi like X. dendrorhous may lack SCAP and INSIG components .
Domain variations: Differences in the C-terminal domain, such as the absence of the DUF2014 domain in X. dendrorhous Sre1 , suggest divergent regulatory mechanisms that could be exploited for species-specific targeting.
Regulatory network differences: While the core targets in sterol biosynthesis are conserved, species-specific targets exist, such as carotenoid biosynthesis genes in X. dendrorhous .
Antifungal implications:
Sre1 activation is essential for resistance to azole antifungals across multiple species
Inhibitors targeting Sre1 activation could sensitize resistant fungi to existing antifungals
Differences in activation mechanisms between species could be exploited for selective targeting
The essentiality of Sre1 for virulence in pathogenic species makes it an attractive drug target
Research approaches to exploit these differences include structural biology studies to identify unique binding sites in pathogen-specific Sre1 proteins, high-throughput screening for inhibitors of Sre1 activation, and combination therapy approaches targeting both Sre1 and ergosterol biosynthesis.
Creating stable recombinant Sre1 constructs presents several challenges due to the protein's membrane association and complex regulatory mechanisms. Common issues and solutions include:
Protein instability: The full-length Sre1 protein is inherently unstable, particularly when separated from its membrane environment. This can be addressed by:
Working with just the N-terminal domain (Sre1N) for transcription factor studies
Using fusion tags that enhance stability (e.g., MBP or SUMO tags)
Including protease inhibitors throughout purification
Expressing in eukaryotic systems rather than bacterial systems
Transmembrane domain complications: The presence of transmembrane domains makes expression and purification challenging. Solutions include:
Using detergent solubilization (e.g., DDM or CHAPS) during extraction
Creating chimeric constructs with more stable transmembrane domains
Employing nanodiscs or liposomes to maintain membrane environment
Post-translational modifications: If studying the regulation of Sre1, key modifications may be missing in heterologous systems. This can be addressed by:
Using S. pombe or similar yeasts as expression hosts
Co-expressing key modifying enzymes
Employing site-directed mutagenesis to mimic phosphorylation states
Expression toxicity: Constitutively active Sre1N may be toxic to expression hosts. Solutions include:
Using tightly controlled inducible promoters
Short induction times with lower temperatures
Screening for non-toxic mutants that retain functionality
The binding of GTP-bound Rho1p to the amino-terminal region of protein kinases dramatically stabilizes these proteins in S. pombe , suggesting that co-expression with appropriate binding partners might similarly enhance Sre1 stability.
Differentiating between direct and indirect Sre1 transcriptional effects requires a multi-faceted approach:
Temporal analysis: Direct targets typically show more rapid expression changes after Sre1 activation. Time-course experiments following Sre1 activation (using systems with inducible Sre1N expression) can help separate primary from secondary effects.
Motif analysis: Direct targets contain SRE motifs in their promoters. Bioinformatic analysis using tools like TFBIND and JASPAR can identify potential SRE sequences, as demonstrated in studies of X. dendrorhous where these tools successfully identified SRE sequences in genes differentially expressed in sre1- mutants .
ChIP experiments: Direct binding of Sre1 to target promoters can be confirmed through ChIP-PCR or ChIP-seq. In research with X. dendrorhous, ChIP-PCR confirmed direct binding of Sre1 to the HMGS gene promoter . Including appropriate negative controls like the grg2 gene, which was confirmed not to be a Sre1 target , is essential.
Reporter assays: Testing the ability of wild-type versus mutated promoter sequences to drive reporter gene expression in response to Sre1 activation can confirm direct regulation.
In vitro binding assays: EMSA assays using purified Sre1N and promoter fragments can confirm direct binding capability, as demonstrated for SRE sequences from the HMGS promoter .
Genetic approach: Creating rapid induction systems where Sre1N activation occurs in the presence of protein synthesis inhibitors can help identify direct targets that don't require new protein synthesis.
A comprehensive approach combining these methods provides the strongest evidence for direct transcriptional regulation by Sre1.
Studying Sre1 function in hypoxic conditions while controlling for secondary effects requires careful experimental design:
Controlled hypoxia systems:
Use anaerobic chambers with precise oxygen control rather than chemical mimics
Implement gradual oxygen reduction to allow adaptive responses
Monitor dissolved oxygen continuously in liquid cultures
Genetic approaches:
Create constitutively active Sre1N mutants to separate Sre1 function from upstream hypoxia sensing
Use conditional mutants (temperature-sensitive) to enable temporal control
Develop orthogonal systems where Sre1 activity can be chemically induced independent of oxygen levels
Distinguishing direct hypoxic effects:
Include controls with alternative stressors that don't affect oxygen (e.g., heat shock)
Compare transcriptional profiles of hypoxia-stressed wild-type cells versus normoxic cells expressing constitutive Sre1N
Use metabolic profiling to distinguish between direct oxygen limitation effects and Sre1-mediated adaptations
Controlling for secondary effects:
Use short time courses to capture immediate responses before secondary effects emerge
Include metabolic supplementation (e.g., ergosterol) to bypass specific pathways
Compare sre1- mutants with specific pathway mutants to isolate Sre1-specific functions
Pharmacological approaches:
Research has shown that S. pombe sre1- mutants are unable to grow under anaerobic conditions or in the presence of cobalt chloride, and this growth defect can be restored by complementation with the native gene , providing a clear phenotypic readout for successful experimental designs.
High-throughput genetic interaction screens offer powerful approaches to uncover new components of Sre1 regulatory networks in S. pombe:
Synthetic genetic array (SGA) methodology:
Crossing sre1- or constitutively active Sre1N strains with genome-wide deletion libraries
Identifying synthetic lethal or synthetic rescue interactions
Quantifying genetic interaction strengths to build functional networks
CRISPR-based screens in S. pombe:
Employing CRISPRi to systematically knock down genes in sre1- backgrounds
Using CRISPR activation (CRISPRa) to identify suppressors of sre1- phenotypes
Conducting tiled CRISPR screens across the Sre1 locus to identify functional domains
Chemical-genetic approaches:
Screening for compounds that specifically affect sre1- mutants
Identifying genes that, when deleted, alter sensitivity to Sre1-activating conditions
Multi-omic integration:
Combining genetic interaction data with transcriptomics, proteomics, and metabolomics
Constructing predictive models of Sre1 regulation and function
Previous screens have already identified unexpected factors involved in related processes, such as the histone H3K4 methyltransferase complex subunits (Set1, Swd1, Swd2, Swd3, Spf1, and Ash2), the BRE1-like ubiquitin ligase Brl2, and the Elongator complex subunit Elp6 in mating-type switching processes . Similar approaches could reveal unexpected connections to Sre1 function.
A particularly promising direction would be to screen for genetic interactions under specific conditions such as hypoxia or sterol depletion, which would enrich for context-specific factors involved in Sre1 regulation.
While the search results don't explicitly discuss non-coding RNAs in Sre1 regulation, this represents an important emerging research direction based on knowledge from related systems:
Potential regulatory mechanisms:
miRNAs targeting Sre1 mRNA for degradation or translational repression
Long non-coding RNAs (lncRNAs) as scaffolds for regulatory protein complexes
Antisense transcripts modulating Sre1 expression
RNA-binding proteins interacting with Sre1 mRNA to affect stability or translation
Experimental approaches to investigate:
RNA immunoprecipitation (RIP) to identify RNAs associated with Sre1 or its regulatory proteins
Small RNA sequencing of wild-type versus mutant strains under various conditions
CRISPR screens targeting annotated non-coding RNAs for effects on Sre1 activity
RNA-protein interaction mapping using techniques like CLIP-seq
Specific research questions:
Do stress-responsive non-coding RNAs modulate Sre1 expression under hypoxia?
Are there RNA structures within the Sre1 mRNA that regulate its translation or localization?
Could antisense transcription at the Sre1 locus provide regulatory feedback?
Do lncRNAs mediate interactions between the Sre1 pathway and other stress response pathways?
The study of non-coding RNAs in S. pombe has been facilitated by the well-annotated genome and powerful genetic tools, making this a feasible avenue for future Sre1 research. Given the complex regulation of Sre1 and its central role in sterol homeostasis and hypoxic adaptation, non-coding RNA involvement would add an important layer to our understanding of its regulation.
Systems biology approaches offer powerful frameworks for integrating diverse experimental data into comprehensive models of Sre1 function:
Multi-omic data integration:
Transcriptomics: RNA-seq data from wild-type, sre1-, and Sre1N-expressing strains under various conditions
Proteomics: Mass spectrometry to capture protein levels and post-translational modifications
Metabolomics: Profiles of sterols, lipids, and other metabolites affected by Sre1
Interactomics: Protein-protein and protein-DNA interaction networks
Network modeling approaches:
Construct directed regulatory networks with Sre1 as a central node
Identify feedback loops and regulatory motifs
Incorporate temporal dynamics of Sre1 activation and target gene expression
Develop predictive models for cellular responses to environmental changes
Computational tools and methodologies:
Machine learning to identify patterns in complex datasets
Bayesian networks to infer causal relationships
Constraint-based modeling to predict metabolic adaptations
Agent-based models to simulate cellular behavior under varying conditions
Specific research applications:
Predicting cellular responses to novel stress conditions
Identifying critical nodes for intervention in pathogenic fungi
Understanding how Sre1 networks evolved across fungal species
Predicting genetic interactions and drug synergies
Validation approaches:
Test model predictions with targeted experiments
Iteratively refine models with new data
Compare model predictions across different fungal species
Research has already begun integrating multiple data types, as seen in studies combining RNA-seq analysis with ChIP-PCR and promoter analysis to identify direct Sre1 targets in X. dendrorhous . These approaches revealed that genes of the mevalonate pathway and ergosterol biosynthesis are transcriptional targets of Sre1, and unexpectedly identified regulation of carotenoid biosynthesis as a species-specific function .